CML and Gleevec


Chronic myeloid leukemia (CML) is caused by a mutation that leads to an abnormal protein that is always active. The drug Gleevec has a shape that fits into the active site of the abnormal protein and stops its harmful effects.

(Duration: 41 sec)
Launch This Resource
Be the first to recommend

By downloading, you agree to the permissions to use this file.